Recently, treatment with biological mediators has been proved efficient in patients with spondylolisthesis – spinal displacement -, offering good results on this pathology.
Dr. Masiá, cardiologist of IMED hospitals, was present during last months in great relevance Conferences of the national and international cardiology area.
First stage of the trials of this drug for Parkinson’s disease with associated dementia where done thanks to a research grant conferred by the Michael J. Fox Foundation for Parkinson’s disease research,
The 40º Endoscopy Congress of the Spanish Society of Gastrointestinal Endoscopy (SEED) took place in Zaragoza from the 14th to the 17th of November.
